SG/PUT/ASTRAZENECA/9000/0.1/20.12.24 | Market Closed - Börse Stuttgart 04:19:57 2024-07-12 am EDT | ||
| 0.054 EUR | +12.50% |
|
| Current month | +22.73% | ||
| 1 month | +1.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.054 | +12.50% |
| 24-07-11 | 0.048 | -17.24% |
| 24-07-10 | 0.058 | +11.54% |
| 24-07-09 | 0.052 | -13.33% |
| 24-07-08 | 0.06 | +15.38% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 04:19 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
Société Générale
|
| WKN | SU796Z |
| ISIN | DE000SU796Z5 |
| Date issued | 2024-02-13 |
| Strike | 9,000 p |
| Maturity | 2024-12-20 (161 Days) |
| Parity | 10 : 1 |
| Emission price | 0.64 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.62 € |
|---|---|
| Lowest since issue | 0.04 € |
| Spread | 0.029 € |
| Spread % | 39.73% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
159.2
USD
Average target price
177.2
USD
Spread / Average Target
+11.26%
- Stock Market
- Warrants
- Warrant
